ISHLT2024: ECP Immunomodulation in Thoracic Transplantation Challenge Grant Selection Session (Non-CME)
11 April, 2024 11:45 a.m. to 12:45 p.m. CEST
Supported by Mallinckrodt Pharmaceuticals
This session will showcase presentations from the five finalists for the ISHLT Extracorporeal Photopheresis Immunomodulation in Thoracic Transplantation Challenge Grant, which will be scored by on site judges. This research grant is aimed at advancing the use of Extracorporeal photopheresis (ECP) immunomodulation to improve patient survival and health-related quality of life (HRQoL) and improve or stabilize organ function in thoracic transplant patients.
The winner will be announced during the General Session on Saturday, 13 April.
Grant Finalists
Mark Petrovic, MS
Vanderbilt University Medical Center
Nashville, TN USA
Research Proposal Title: Immunomodulation using Extracorporeal Photopheresis in Human-Xenogeneic Cross-Circulation
Ayyaz Ali, MD, PhD
Hartford Hospital
Hartford, CT USA
Research Proposal Title: Attenuation of Immune-Mediated Cardiac Injury after Extracorporeal Photopheresis: Insight from Isolated Heart Perfusion using a Swine Cross-Circulation Model
Rachel Crossland, PhD
Newcastle University
Newcastle upon Tyne, United Kingdom
Research Proposal Title: Extracellular Vesicles as Novel Tools in the Management of ECP for Chronic Lung Allograft Dysfunction (EVENT-CLAD)
Andrea Fernandez Valledor, MD
New York Presbyterian / Columbia Irving Medical Center
New York, NY USA
Research Proposal Title: Effect of Extracorporeal Photopheresis Therapy in Heart Transplant Recipients with DSA and Presumptive AMR
Samuel Priyaranjan, MBBS, DTCD, DNB
Krishna Institute of Medical Sciences
Hyderabad, India
Research Proposal Title: Immunomodulation with a Combination of Extracorporeal Photopheresis (ECP) with Ultra Low Dose Il2 and Jak 1/2 Inhibitors